He has published more than 470 peer-reviewed manuscripts, invited reviews, and book chapters in the areas of liver toxicology and liver pathophysiology (“h-factor 115”; >51,000 citations - Google Scholar). Dr. Jaeschke was a standing member of the Hepatobiliary Pathophysiology NIH study section (2008-2013) and served as ad-hoc member on numerous additional NIH grant review committees. In the past, Dr. Jaeschke served on the Editorial Boards of Hepatology, American Journal of Physiology: Liver and Gastrointestinal Physiology, Gastroenterology and Journal of Hepatology; he was an Associate Editor for Hepatology (2002–2006) and Liver International (2007–2012). He currently serves as Associate Editor for Toxicological Sciences (since 2014) and 4 other journals; in addition, he is inaugural Editor-in-Chief of Livers (since 2020) and member of 14 editorial boards. In 2019, he was the recipient of the Translational Impact Award from the Society of Toxicology. His major research interests include basic mechanisms and translational aspects of xenobiotic-induced hepatotoxicity and tissue repair with focus on acetaminophen overdose and mechanisms of inflammatory liver injury in animal models and humans.